Taiwan Semiconductor, Johnson & Johnson and Palantir headline today's analyst reports, with AI growth, drug pipelines and competitive pressures shaping their outlooks.
Taiwan Semiconductor, Johnson & Johnson and Palantir headline today's analyst reports, with AI growth, drug pipelines and competitive pressures shaping their outlooks.
Altigen's fiscal Q3 earnings per share remain flat year over year as cloud services weaken, while a lower gross margin adds pressure, partly offset by reduced operating expenses.
ATGN's AI-driven CXaaS transformation, higher recurring revenue, strategic partnerships and scalable operations position the company for accelerating growth and improving profitability.
Altigen's fiscal Q1 results face revenue decline from legacy platform transition, but strong margins, cost control and upcoming AI launches signal potential growth in the second half of FY2026.